A randomized double blind study to investigate the effect of APC-2000 in patients with mild to moderate asthma.

Trial Profile

A randomized double blind study to investigate the effect of APC-2000 in patients with mild to moderate asthma.

Completed
Phase of Trial: Phase II

Latest Information Update: 21 Apr 2015

At a glance

  • Drugs Salbutamol (Primary)
  • Indications Asthma
  • Focus Pharmacokinetics
  • Most Recent Events

    • 21 Apr 2015 New trial record
    • 16 Apr 2015 Primary endpoint (The equivalence of change from baseline in Forced Expiratory Volume (FEV1 AUC 0-6 hours) between the two HFA aerosols assessed at two different doses (100 and 200 mcg)) met, as per Adamis Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top